HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Emerging Markets Compound Stagnation In Developed Economies

This article was originally published in The Tan Sheet

Executive Summary

The rapid growth of emerging markets – key regions for many OTC firms – is a major contributor to the industrialized world’s economic stagnation, an HSBC analyst says. Emerging market growth hinders recovery in developed markets by driving up commodity and oil costs, breaking the link in the traditional boom-bust economic cycle.

You may also be interested in...

Multinationals Turn To Smaller Markets To Avoid BRIC Restrictions

Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.

Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost

After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. managed to sell its growing nutritional business to French food giant Group Danone for a reported $354 million

Reckitt Continues Asian Push With $724M Paras Purchase

Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts